Takaya Hiroaki 高谷広章

Researcher Number	40745460
Other IDs
Affiliation (Current)	2025: 奈良県立医科大学, 医学部附属病院, 研究員
Affiliation (based on the past Project Information) *help	2022 – 2025: 奈良県立医科大学, 医学部附属病院, 研究員 2021: 奈良県立医科大学, 医学部, 医員 2019 – 2020: 奈良県立医科大学, 医学部, 学内講師
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related Except Principal Investigator Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator バイオマーカー / VWF / ADAMTS13 / 肝癌 / 急性腎障害 / ACLF / 急性肝不全 / WF / ADAMT13 / HCC / 肝細胞癌 Except Principal Investigator サルコペニア

血液凝固制御因子ADAMTS13による肝癌再発予防法とバイオマーカーの開発Principal Investigator
- Principal Investigator
  
  高谷広章
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nara Medical University
A new strategy for the treatment of cirrhotic sarcopenia using a combination of exercise therapy and ADAMTS13 replacement therapy.
- Principal Investigator
  
  浪崎正
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nara Medical University
血液凝固制御因子ADAMTS13による急性肝不全新規治療法とバイオマーカーの開発Principal Investigator
- Principal Investigator
  
  高谷広章
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nara Medical University
The association between VWF and HCCPrincipal Investigator
- Principal Investigator
  
  Takaya Hiroaki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nara Medical University

All 2024 2023 2022 2021 2020 2019

All Journal Article Presentation Book

[Book] Thrombosis Medicine　9/3　2019年9月号2019
- Author(s)
  高谷広章
- Total Pages
  89
- Publisher
  先端医学社
- ISBN
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis2024
- Author(s)
  Asada Shohei、Namisaki Tadashi、Kaji Kosuke、Takaya Hiroaki、et al
- Journal Title
  
  Digestive Diseases and Sciences
  
  Volume: 69 Issue: 3 Pages: 851-869
- DOI
  10.1007/s10620-023-08257-w
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08084
[Journal Article] The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure2023
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Enomoto Masahide、Kubo Takahiro、Tsuji Yuki、Fujinaga Yukihisa、Nishimura Norihisa、Kaji Kosuke、Kawaratani Hideto、Moriya Kei、Akahane Takemi、Matsumoto Masanori、Yoshiji Hitoshi
- Journal Title
  
  Biology
  
  Volume: 12 Issue: 2 Pages: 164-164
- DOI
  10.3390/biology12020164
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08084
[Journal Article] Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa? and VIVA? Systems2022
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Matsumoto Kazusuke、Suzuki Junya、Murata Koji、Tsuji Yuki、Nakanishi Keisuke、Kaji Kosuke、Kitade Mitsuteru、Noguchi Ryuichi、Yoshiji Hitoshi
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 11 Issue: 2 Pages: 434-434
- DOI
  10.3390/jcm11020434
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] The Combination of Albumin?Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child?Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria2021
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Takeda Soichi、Kaji Kosuke、Ogawa Hiroyuki、Ishida Koji、Tsuji Yuki、Takagi Hirotetsu、Ozutsumi Takahiro、Fujinaga Yukihisa、Furukawa Masanori、Kitagawa Koh、Nishimura Norihisa、Sawada Yasuhiko、Shimozato Naotaka、Kawaratani Hideto、Moriya Kei、Akahane Takemi、Mitoro Akira、et. al
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 10 Issue: 21 Pages: 4838-4838
- DOI
  10.3390/jcm10214838
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] Association between ADAMTS13 activity?VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma2020
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Moriya Kei、Shimozato Naotaka、Kaji Kosuke、Ogawa Hiroyuki、Ishida Koji、Tsuji Yuki、Kaya Daisuke、Takagi Hirotestu、Fujinaga Yukihisa、Nishimura Norihisa、Sawada Yasuhiko、Kawaratani Hideto、Akahane Takemi、Matsumoto Masanori、Yoshiji Hitoshi
- Journal Title
  
  World Journal of Gastroenterology
  
  Volume: 26 Issue: 45 Pages: 7232-7241
- DOI
  10.3748/wjg.v26.i45.7232
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma2019
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Shimozato Naotaka、Kaji Kosuke、Kitade Mitsuteru、Moriya Kei、Sato Shinya、Kawaratani Hideto、Akahane Takemi、Matsumoto Masanori、Yoshiji Hitoshi
- Journal Title
  
  World Journal of Gastrointestinal Oncology
  
  Volume: 11 Issue: 5 Pages: 424-435
- DOI
  10.4251/wjgo.v11.i5.424
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma2019
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Kitade Mitsuteru、Kaji Kosuke、Nakanishi Keisuke、Tsuji Yuki、Shimozato Naotaka、Moriya Kei、Seki Kenichiro、Sawada Yasuhiko、Saikawa Soichiro、Sato Shinya、Kawaratani Hideto、Akahane Takemi、Noguchi Ryuichi、Matsumoto Masanori、Yoshiji Hitoshi
- Journal Title
  
  BMC Gastroenterology
  
  Volume: 19 Issue: 1
- DOI
  10.1186/s12876-019-1082-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17442
[Journal Article] Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients2019
- Author(s)
  Takaya Hiroaki、Namisaki Tadashi、Kitade Mitsuteru、Shimozato Naotaka、Kaji Kosuke、Tsuji Yuki、Nakanishi Keisuke、Noguchi Ryuichi、Fujinaga Yukihisa、Sawada Yasuhiko、Saikawa Soichiro、Sato Shinya、Kawaratani Hideto、Moriya Kei、Akahane Takemi、Yoshiji Hitoshi
- Journal Title
  
  World Journal of Gastrointestinal Oncology
  
  Volume: 11 Issue: 10 Pages: 887-897
- DOI
  10.4251/wjgo.v11.i10.887
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] Comparison of ablation area and change in functional liver reserve after radiofrequency ablation for hepatocellular carcinoma using the arfa and VIVA Systems2022
- Author(s)
  Hiroaki Takaya, Tadashi Namisaki, Yuki Tsuji, Kosuke Kaji, Shigeyuki Aizawa, Chie Morioka, Ryuichi Noguchi, Motoyuki Yoshida, Hitoshi Yoshiji
- Organizer
  APASL Oncology 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] ACLFにおけるADAMTS13の動態2022
- Author(s)
  高谷広章, 浪崎正, 鍛治孝祐, 西村典久, 吉治仁志
- Organizer
  第48回日本急性肝不全研究会
- Data Source
  KAKENHI-PROJECT-22K08084
[Presentation] ACLFにおけるADAMTS13の動態2022
- Author(s)
  高谷広章, 浪﨑正, 吉治仁志
- Organizer
  JDDW2022
- Data Source
  KAKENHI-PROJECT-22K08084
[Presentation] The combination of ALBI and PT predict liver dysfunction after TACE for HCC within up-to-7 criteria2021
- Author(s)
  Hiroaki Takaya, Tadashi Namisaki, Soichi Takeda, Kosuke Kaji, Hitoshi Yoshiji
- Organizer
  APASL Oncology 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] BCLC-B1の肝細胞癌患者における肝動脈化学塞栓術および分子標的薬治療前後での肝予備能の変化に寄与する因子の検討2021
- Author(s)
  竹田惣一、高谷広章、浪崎正、吉治仁志
- Organizer
  日本消化器病学会近畿支部第114回例会
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] BCLC-B1の肝細胞癌における肝動脈化学塞栓術および分子標的薬治療前後での肝予備能の変化に寄与する因子の検討2020
- Author(s)
  竹田惣一、高谷広章、浪崎正、吉治仁志
- Organizer
  日本消化器病学会近畿支部第114回例会
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] 非NASH症例におけるアシルカルニチンの肝細胞癌早期診断マーカーとしての有用性2020
- Author(s)
  高谷広章
- Organizer
  第21回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] 進行肝細胞癌においてvon Willebrand factorおよびADAMTS13はソラフェニブ治療効果および予後予測因子に成り得る2020
- Author(s)
  藤本優樹、高谷広章、浪崎正、辻裕樹、下里直隆、鍛治孝祐、吉治仁志
- Organizer
  第22回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] 進行肝細胞癌に対するネクサバール治療効果および予後予測因子としてのvon Willebrand factorおよびADAMTS13の有用性2019
- Author(s)
  高谷広章
- Organizer
  第20回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] 非NASH症例における肝癌診断マーカーとしてのアシルカルニチンの有用性2019
- Author(s)
  高谷広章
- Organizer
  第27回日本消化器関連学会週間
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma2019
- Author(s)
  Hiroaki Takaya
- Organizer
  AASLD2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17442
[Presentation] von Willebrand factorおよびADAMTS13を用いた肝発癌、肝癌早期診断および治療効果予測の試み2019
- Author(s)
  高谷広章
- Organizer
  第55回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-19K17442

1. 浪崎正 (20526850)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
2. 鍛治孝祐 (20623490)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
3. 吉治仁志 (40336855)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
4. 井上隆 (00783044)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 芝本彰彦 (20896724)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 佐藤慎哉 (80790352)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Takaya Hiroaki 高谷 広章

Research Projects

Research Products

Co-Researchers

血液凝固制御因子ADAMTS13による肝癌再発予防法とバイオマーカーの開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A new strategy for the treatment of cirrhotic sarcopenia using a combination of exercise therapy and ADAMTS13 replacement therapy.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

血液凝固制御因子ADAMTS13による急性肝不全新規治療法とバイオマーカーの開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The association between VWF and HCCPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Book] Thrombosis Medicine 9/3 2019年9月号2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa? and VIVA? Systems2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Combination of Albumin?Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child?Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association between ADAMTS13 activity?VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Comparison of ablation area and change in functional liver reserve after radiofrequency ablation for hepatocellular carcinoma using the arfa and VIVA Systems2022

Author(s)

Organizer

Data Source

[Presentation] ACLFにおけるADAMTS13の動態2022

Author(s)

Takaya Hiroaki 高谷広章

[Book] Thrombosis Medicine　9/3　2019年9月号2019

[Presentation] 進行肝細胞癌においてvon Willebrand factorおよびADAMTS13はソラフェニブ治療効果および予後予測因子に成り得る2020